Black patients undergoing CABG may have worse outcomes than their white counterparts. A comparison of 11,697 black and 136,363 white patients undergoing CABG has indicated that black patients tend to be younger, have greater comorbidities and adverse presenting features. Unadjusted mortality and morbidity were greater in black patients and these persisted after adjustment for surgeon, hospital and care processes.
The internal mammary artery (IMA) is the conduit of choice for the left anterior descending (LAD) artery. Data on the frequency and predictors of IMA failure are sparse. Data from the PREVENT IV study have shown that IMA failure occurred in 8.6% of patients with predictors of such failure being LAD stenosis <75%, additional bypass graft to diagonal branches, and absence of diabetes. IMA failure was associated with increased rates of repeat revascularization.
The long-term benefits of bariatric surgery are uncertain. A study of 242 adolescents undergoing Roux-en-Y gastric bypass or sleeve gastrectomy over a period of 3 years has demonstrated that that procedure led to a 27% reduction in weight, 95% remission in type 2 diabetes, 86% remission of abnormal kidney function, 74% remission of hypertension, and 66% remission of dyslipidemia. Iron deficiency was identified in 57% of the participants, and 13% required one or more additional procedures.
Data regarding the port of microbial entry leading to infective endocarditis are scarce. In a study of 318 patients, the skin, oral or dental and the GI route were the three most common routes of entry accounting for 62%, 29%, and 23% of case, respectively. Intravenous drug use, dental infection colonic polys and colorectal adenocarcinoma were among common sources of infection in each category.
by Nicole Lou Reporter, MedPage Today/CRTonline.org
E Meliga, HM García-García, N Kukreja, J Daemen, S Tanimoto, S Ramcharitar, CAG van Mieghem, G Sianos, M van der Ent, WJ van der Giessen, P de Feyter, R van Domburg, PW Serruys
Courtesy of www.theheart.org
R Sakurai, Y Hongo, M Yamasaki, Y Honda, HN Bonneau, PG Yock, D Cutlip, JJ Popma, P Zimetbaum, J Fajadet, et al.
What is your first line of therapy for restenosis of DES?
Drug Coated Balloon
Another Drug Eluting Stent
Carlo Di Mario, MD
Stephan Windecker, MD
Patrick W Serruys MD, PhD
Ashish H. Shah, MD, MRCP, et al.
Tarek Helmy, MD
J. Aaron Grantham, MD
Prof. Sigmund Silber, MD
Alexandre Abizaid, MD, PhD
Raul Moreno, MD, et al.
Ian Meredith, MD
CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.